Stavrianeas NG - Search Results

1

CCR2-64I and CXCL12 3'A alleles confer a favorable prognosis to AIDS patients undergoing HAART therapy.

Passam AM, Zafiropoulos A, Miyakis S, Zagoreos I, Stavrianeas NG, Krambovitis E, Spandidos DA. Passam AM, et al. Among authors: stavrianeas ng. J Clin Virol. 2005 Dec;34(4):302-9. doi: 10.1016/j.jcv.2004.05.021. J Clin Virol. 2005. PMID: 16286054

2

Polymorphisms of Cx(3)CR1 and CXCR6 receptors in relation to HAART therapy of HIV type 1 patients.

Passam AM, Sourvinos G, Krambovitis E, Miyakis S, Stavrianeas N, Zagoreos I, Spandidos DA. Passam AM, et al. AIDS Res Hum Retroviruses. 2007 Aug;23(8):1026-32. doi: 10.1089/aid.2006.0248. AIDS Res Hum Retroviruses. 2007. PMID: 17725420

3

Concurrent CMV and EBV DNAemia is significantly correlated with a delay in the response to HAART in treatment-naive HIV type 1-positive patients.

Panagiotakis SH, Soufla G, Baritaki S, Sourvinos G, Passam A, Zagoreos I, Stavrianeas N, Spandidos DA. Panagiotakis SH, et al. AIDS Res Hum Retroviruses. 2007 Jan;23(1):10-8. doi: 10.1089/aid.2006.0083. AIDS Res Hum Retroviruses. 2007. PMID: 17263627

4

Anti-HHV-8/KSHV antibodies in infected individuals inhibit infection in vitro.

Dialyna IA, Graham D, Rezaee R, Blue CE, Stavrianeas NG, Neisters HG, Spandidos DA, Blackbourn DJ. Dialyna IA, et al. Among authors: stavrianeas ng. AIDS. 2004 Jun 18;18(9):1263-70. doi: 10.1097/00002030-200406180-00004. AIDS. 2004. PMID: 15362658

5

Kaposi sarcoma (KS)-associated herpesvirus microRNA sequence analysis and KS risk in a European AIDS-KS case control study.

Marshall V, Martró E, Labo N, Ray A, Wang D, Mbisa G, Bagni RK, Volfovsky N, Casabona J, Whitby D; EURO-SHAKS Study Group. Marshall V, et al. J Infect Dis. 2010 Oct 1;202(7):1126-35. doi: 10.1086/656045. J Infect Dis. 2010. PMID: 20715927 Free PMC article.

6

Response of AIDS-associated Kaposi sarcoma to highly active antiretroviral therapy alone.

Paparizos VA, Kyriakis KP, Papastamopoulos V, Hadjivassiliou M, Stavrianeas NG. Paparizos VA, et al. Among authors: stavrianeas ng. J Acquir Immune Defic Syndr. 2002 Jun 1;30(2):257-8. doi: 10.1097/00042560-200206010-00015. J Acquir Immune Defic Syndr. 2002. PMID: 12045689 No abstract available.

7

Leishmaniasis in Greece II. Isolation and identification of the parasite causing cutaneous leishmaniasis in man.

Garifallou A, Schnur LF, Stratigos JD, Hadziandoniou M, Savigos M, Stavrianeas N, Sérié C. Garifallou A, et al. Ann Trop Med Parasitol. 1984 Aug;78(4):369-75. doi: 10.1080/00034983.1984.11811834. Ann Trop Med Parasitol. 1984. PMID: 6433815

8

The role of inflammatory markers in assessing disease severity and response to treatment in patients with psoriasis treated with etanercept.

Kanelleas A, Liapi C, Katoulis A, Stavropoulos P, Avgerinou G, Georgala S, Economopoulos T, Stavrianeas NG, Katsambas A. Kanelleas A, et al. Among authors: stavrianeas ng. Clin Exp Dermatol. 2011 Dec;36(8):845-50. doi: 10.1111/j.1365-2230.2011.04131.x. Epub 2011 Jul 25. Clin Exp Dermatol. 2011. PMID: 21790728

9

Seborrheic dermatitis: lifetime detection rates.

Palamaras I, Kyriakis KP, Stavrianeas NG. Palamaras I, et al. Among authors: stavrianeas ng. J Eur Acad Dermatol Venereol. 2012 Apr;26(4):524-6. doi: 10.1111/j.1468-3083.2011.04079.x. Epub 2011 Apr 27. J Eur Acad Dermatol Venereol. 2012. PMID: 21521374 No abstract available.

10

Fixed drug eruption caused by dimenhydrinate.

Giatrakou S, Papadavid E, Kalogeromitros D, Theodoropoulos K, Toumbis-Ioannou E, Makris M, Stavrianeas NG. Giatrakou S, et al. Among authors: stavrianeas ng. J Am Acad Dermatol. 2011 Mar;64(3):608-10. doi: 10.1016/j.jaad.2009.07.001. J Am Acad Dermatol. 2011. PMID: 21315964 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page